Microbial Cell Factories
BioMed Central
Open Access
Poster Presentation
Expression of functional recombinant rabies virus glycoprotein in Drosophila melanogaster S2 cells Adriana Y Yokomizo1, Soraia AC Jorge1, Renato M Astray1, Mariza AG Santos1, Irene Fernandes2, Orlando G Ribeiro3, Denise SPQ Horton4, Aldo Tonso5 and Carlos A Pereira*1 Address: 1Laboratório de Imunologia Viral, Instituto Butantan, 05503-900 São Paulo, Brasil, 2Laboratório de Imunopatologia, Instituto Butantan, 05503-900 São Paulo, Brasil, 3Laboratório de Imunogenética, Instituto Butantan, 05503-900 São Paulo, Brasil, 4Serviço de Controle de Qualidade, Instituto Butantan, 05503-900 São Paulo, Brasil and 5Departamento de Engenharia Química, Escola Politécnica, Universidade de São Paulo, Brasil * Corresponding author
from The 4th Recombinant Protein Production Meeting: a comparative view on host physiology Barcelona, Spain. 21–23 September 2006 Published: 10 October 2006 Microbial Cell Factories 2006, 5(Suppl 1):P89
doi:10.1186/1475-2859-5-S1-P89
The 4th Recombinant Protein Production Meeting: a comparative view on host physiology
The organisers would like to thank Novozymes Delta Ltd who generously supported the meeting. Meeting abstracts – A single PDF containing all abstracts in this supplement is available
here http://www.biomedcentral.com/content/pdf/1475-2859-5-S1-info.pdf
© 2006 Yokomizo et al; licensee BioMed Central Ltd.
The rabies virus belongs to the genus Lyssavirus from the Rhabdoviridae family and is widely distributed in nature infecting mammals. Upon infection it can be transmitted to animals or humans and leads to a fatal disease that nowadays has no treatment. Vaccines are commercially available and prevent the disease in animals and humans. Protocols for human or veterinarian vaccine manufacturing evolved from animal tissue homogenates to cell culture technology and today recombinant viral proteins and DNA vaccines are under investigation. The evidence that rabies virus infects and can cause disease in animals and humans, being neutralized by an immune response mounted by very similar vaccines opens a great possibility of testing new vaccines first in experimental animals prior to use in humans [1].
when compared to the non transfected cells (S2). They were shown, by PCR, to express the GPV gene and mRNA as well as, by immunoblotting, to synthesize the rGPV in its expected molecular weight of 65 kDa. ELISA kinetic studies showed the rGPV expression in cell lysates and supernatants attaining concentrations ranging from 150 to 300 μg of rGPV/L. By flow cytometry analysis, about 30% of the cells in these populations were shown to express the rGPV in their membrane. Cell populations selected by limiting dilution expressed higher rGPV yields. Mice immunized with S2MtGPV or S2AcGPV derived rGPV were capable of mounting a protective immune response characterized by the synthesis of antibodies reacting against the rabies virus. Immunization led to protection against rabies virus experimental infection in challenge studies.
Results
Conclusion
Recombinant rabies vírus glycoprotein (rGPV) was expressed in Drosophila melanogaster Schneider 2 (S2) cells. The cDNA encoding the GPV gene was cloned in expression plasmids under the control of the inducible metallothionein promoter (Mt) or the constitutive actin promoter (Ac). These were alternatively co-transfected into S2 cells together with a hygromycin selection plasmid. Selected S2 cell populations (S2MtGPV or S2AcGPV) had a decreased ability to grow and consume substrates,
The data presented here show that S2 cells are suitable hosts for the rGPV expression allowing its synthesis in a high degree of physical and biological integrity.
Background
Acknowledgements This work was supported in part by grants and scholarships from the FAPESP, CNPq, CAPES and Fundação Butantan. C. A. Pereira is recipient of CNPq research fellowships. We thank M.J.S. Leme for technical assistance performing "in vivo" challenge assays.
Page 1 of 2 (page number not for citation purposes)
Microbial Cell Factories 2006, 5(Suppl 1):P89
References 1.
Warrel MJ, Warrel DA: Rabies and other lyssavirus diseases. Lancet 2004, 363:959-969.
Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime." Sir Paul Nurse, Cancer Research UK
Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright
BioMedcentral
Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp
Page 2 of 2 (page number not for citation purposes)
